Trial intelligence / Profile preview

Micronized dHACM (AmnioFix) for Plantar Fasciitis

NCT03414268Phase 3Completed

Sponsor
MIMEDX
Start
Jan 2018
Primary completion
Mar 2021
Modality
Implantable Devices, Implantable Hydrogels, Tissue Cells
Countries
1
01

Overview

A Phase 3 trial of AmnioFix in plantar fasciitis, sponsored by MIMEDX. Started Jan 2018; status: completed.

02

Drugs

AmnioFix
03

Conditions

plantar fasciitis

Beyond the preview

Go deeper on NCT03414268.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03414268.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call